Items where contributor is "Herrmann, Richard"

2011

Rochlitz, C. and Ruhstaller, T. and Lerch, S. and Spirig, C. and Huober, J. and Suter, T. and Buhlmann, M. and Fehr, M. and Schonenberger, A. and von Moos, R. and Winterhalder, R. and Rauch, D. and Muller, A. and Mannhart-Harms, M. and Herrmann, R. and Cliffe, B. and Mayer, M. and Zaman, K.. (2011) Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer : a multicenter, single-arm phase II trial (SAKK 24/06). Annals of Oncology, Vol. 22, H. 1. pp. 80-85.

2010

Wicki, Andreas and Herrmann, Richard and Christofori, Gerhard. (2010) Kras in metastatic colorectal cancer. Swiss Medical Weekly, Vol. 140 , w13112.

Haschke, M. and Vitins, T. and Lude, S. and Todesco, L. and Novakova, K. and Herrmann, R. and Krahenbuhl, S.. (2010) Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs. Nephrology, dialysis, transplantation, Vol. 25, H. 2. pp. 426-433.

Hess, V. and Pratsch, S. and Potthast, S. and Lee, L. and Winterhalder, R. and Widmer, L. and Cescato, C. and Lohri, A. and Jost, L. and Stillhart, P. and Pestalozzi, B. and Herrmann, R.. (2010) Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC) : a phase I/II trial. Annals of Oncology, Vol. 21, H. 12. pp. 2390-2395.

Bernhard, J. and Dietrich, D. and Glimelius, B. and Hess, V. and Bodoky, G. and Scheithauer, W. and Herrmann, R.. (2010) Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy. British journal of cancer, Vol. 103, no. 9. pp. 1318-1324.

Brauchli, Peter and Thürlimann, Beat and Crowe, Susanne N. and Herrmann, Richard. (2010) What is the value of the 21-gene recurrence score? Journal of clinical oncology, Vol. 28 , e671-e672.

2009

Cunningham, David and Chau, Ian and Stocken, Deborah D. and Valle, Juan W. and Smith, David and Steward, William and Harper, Peter G. and Dunn, Janet and Tudur-Smith, Catrin and West, Julia and Falk, Stephen and Crellin, Adrian and Adab, Fawzi and Thompson, Joyce and Leonard, Pauline and Ostrowski, Joe and Eatock, Martin and Scheithauer, Werner and Herrmann, Richard and Neoptolemos, John P.. (2009) Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27. pp. 5513-5518.

Buess, Martin and Rajski, Michal and Vogel-Durrer, Brigitte M. L. and Herrmann, Richard and Rochlitz, Christoph. (2009) Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer. Neoplasia, Vol. 11. pp. 987-1002.

Lippert, Eric and Girodon, François and Hammond, Emma and Jelinek, Jaroslav and Reading, N. Scott and Fehse, Boris and Hanlon, Katy and Hermans, Mirjam and Richard, Céline and Swierczek, Sabina and Ugo, Valérie and Carillo, Serge and Harrivel, Véronique and Marzac, Christophe and Pietra, Daniela and Sobas, Marta and Mounier, Morgane and Migeon, Marina and Ellard, Sian and Kröger, Nicolaus and Herrmann, Richard and Prchal, Josef T. and Skoda, Radek C. and Hermouet, Sylvie. (2009) Concordance of assays designed for the quantification of JAK2V617F : a multicenter study. Haematologica : journal of hematology, Vol. 94. pp. 38-45.

Herrmann, Richard and Lorenz, Matthias and Zuber, Markus and Rufibach, Kaspar and Laffer, Urban. (2009) Perioperative and adjuvant chemotherapy in colon cancer : results of SAKK trial 40/93. International journal of colorectal disease, Vol. 24, H. 3. pp. 351-352.

2008

Hess, V. and Glimelius, B. and Grawe, P. and Dietrich, D. and Bodoky, G. and Ruhstaller, T. and Bajetta, E. and Saletti, P. and Figer, A. and Scheithauer, W. and Herrmann, R.. (2008) CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. The Lancet oncology, Vol. 9. pp. 132-138.

Heinrich, M. C. and Joensuu, H. and Demetri, G. D. and Corless, C. L. and Apperley, J. and Fletcher, J. A. and Soulieres, D. and Dirnhofer, S. and Harlow, A. and Town, A. and McKinley, A. and Supple, S. G. and Seymour, J. and Di Scala, L. and van Oosterom, A. and Herrmann, R. and Nikolova, Z. and McArthur, A. G.. (2008) Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases. Clinical cancer research, Vol. 14. pp. 2717-2725.

Bernhard, J. and Dietrich, D. and Scheithauer, W. and Gerber, D. and Bodoky, G. and Ruhstaller, T. and Glimelius, B. and Bajetta, E. and Schüller, J. and Saletti, P. and Bauer, J. and Figer, A. and Pestalozzi, B. C. and Köhne, C. H. and Mingrone, W. and Stemmer, S. M. and Tàmas, K. and Kornek, G. V. and Koeberle, D. and Herrmann, R. and Central, European Cooperative Oncology Group. (2008) Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone : a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology, Vol. 26. pp. 3695-3701.

Koeberle, D. and Saletti, P. and Borner, M. and Gerber, D. and Dietrich, D. and Caspar, C. B. and Mingrone, W. and Beretta, K. and Strasser, F. and Ruhstaller, T. and Mora, O. and Herrmann, R. and Swiss, Group for Clinical Cancer Research. (2008) Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine : a multicenter, phase II trial of the swiss group for clinical cancer research. Journal of clinical oncology, Vol. 26. pp. 3702-3708.

Thürlimann, B. and Bonnefoi, H. and Cameron, D. and Goldhirsch, A. and Herrmann, R. and Monnerat, C. and von Moos, R. and Pagani, O. and Perey, L. and Pestalozzi, B. and Rochlitz, C. and Suter, T.. (2008) Adjuvant therapy of HER2-positive breast cancer with trastuzumab. Senologie, Vol. 5. pp. 1-3.

Laffer, U. and Metzger, U. and Aeberhard, P. and Lorenz, M. and Harder, F. and Maibach, R. and Zuber, M. and Herrmann, R.. (2008) Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer : long-term results of a randomized controlled trial. International journal of colorectal disease, Vol. 23, H. 12. pp. 1233-1241.

Lindpaintner, L. and Grüninger, T. and Nega, S. and Seidegger, C. and Spoendlin, M. and Stoll, A. and Herrmann, R.. (2008) Kommunikation und Vernetzung in der Onkologie. Care management, Vol. 1. pp. 38-40.

Herrmann, R. and Jelic, S. and Esmo, Guidelines Working Group. (2008) Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, Vol. 19 , ii25-6.